SCHEMBL13101024

SCHEMBL13101024

CC(C)CC(=O)CNC(=O)c1ccncc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.51
TSHR P16473 1/20 0.51
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
PTGS2 P35354 1/20 0.50
NAAA Q02083 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MPO P05164 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2A6 P11509 1/20 0.49
CYP2C19 P33261 1/20 0.49
ALDH1A1 P00352 1/20 0.47
EPHX2 P34913 1/20 0.47
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13101025 0.82 GFER (0.47) SMN1; SMN2KDM4EMPOCYP1A2CYP3A4
SCHEMBL13113102 0.81 NAAA (0.57) L3MBTL1TSHRNAAASMN1; SMN2KDM4E
SCHEMBL11004617 0.81 ALDH1A1 (0.52) SMN1; SMN2KDM4EALDH1A1HPGDLMNA
SCHEMBL11007393 0.81 GPR139 (0.55) L3MBTL1TSHRMAOBSMN1; SMN2KDM4E
SCHEMBL13101448 0.80 L3MBTL1 (0.54) L3MBTL1TSHRMAOAMAOBPTGS2
SCHEMBL6755723 0.80 NAMPT (0.63) L3MBTL1TSHRMAOAMAOBPTGS2
SCHEMBL14990877 0.78 CYP1A2 (0.57) L3MBTL1TSHRNAAASMN1; SMN2KDM4E
SCHEMBL7868060 0.77 EPHX2 (0.65) L3MBTL1TSHRMAOAMAOBPTGS2
SCHEMBL8581111 0.75 KDM4E (0.61) L3MBTL1NAAASMN1; SMN2KDM4EMPO
SCHEMBL2996632 0.75 ALDH1A1 (0.63) L3MBTL1MAOAMAOBPTGS2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530646-B2 Oxazolidinone derivative having 7-membered hetero ring RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2013-09-10 US disclosed
US-20100256355-A1 OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING Research Foundation ITSUU Laboratory and Shionogi & Co., Ltd. 2010-10-07 US disclosed
US-20100256355-A1 OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING Research Foundation ITSUU Laboratory and Shionogi & Co., Ltd. 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256355-A1 OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING NR0B2, NR0B1, NR2C2 L3MBTL1 1838/4885TSHR 733/4885MAOA 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.